Wed, June 16, 2021
Tue, June 15, 2021
Mon, June 14, 2021

Christopher Raymond Initiated (ACRS) at Buy and Held Target at $30 on, Jun 15th, 2021

Christopher Raymond of Piper Sandler, Initiated "Aclaris Therapeutics, Inc." (ACRS) at Buy and Held Target at $30 on, Jun 15th, 2021.

Christopher has made no other calls on ACRS in the last 4 months.



There are 2 other peers that have a rating on ACRS. Out of the 2 peers that are also analyzing ACRS, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Christopher


  • Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $40 on, Wednesday, April 21st, 2021
  • Thomas Smith of "SVB Leerink" Maintained at Buy with Increased Target to $26 on, Thursday, March 4th, 2021